Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Becton Dickinson and Co    BDX

Delayed Quote. Delayed  - 07/22 10:01:13 pm
173.67 USD   -0.68%
07/19 BUSINESS MACHIN : IBM Releases 2015 Corporate Responsibility Report
07/19 BECTON DICKINSO : BD Hits Century Mark With Infusion Pump Interopera..
07/13 BECTON DICKINSO : For Vet. Lab. Supplies Becton Dickinson
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Becton Dickinson's 1st-Quarter Earnings Surge; Raises Year-View

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/05/2013 | 12:50pm CEST
   By Saabira Chaudhuri 
 

Becton Dickinson & Co.'s (>> Becton, Dickinson and Co.) fiscal first-quarter earnings more than doubled as the medical device maker recorded revenue growth across all its segments, while margins also widened.

For the current year, Becton raised the bottom end of its revenue guidance, now expecting foreign currency neutral revenue growth starting at 4% versus its prior view starting at 3.5%. It now expects per-share earnings from continuing operations between $5.69 and $5.72, up from its prior view of earnings between $5.58 and $5.64.

The maker of products like surgical blades and test kits last spring struck a deal to sell the bulk of its lab-products business to Corning Inc. (>> Corning Incorporated) for $730 million in cash. Analysts who follow the company noted the sale stripped Becton Dickinson of a cash cow yet also gave it the freedom to focus on businesses with higher growth potential.

Ahead of the company's earnings announcement, analysts at Mizuho Securities downgraded Becton's ratings, noting that the company's life science research business--which makes up about 15% of sales--has been a drag on results for the past year, adding that they see no significant catalysts for the business in the near-term, as the academic market continues to be sluggish.

Still, Chief Executive Vincent A. Forlenza on Tuesday said the company is "starting to see notable results," adding that Becton is "growing revenues across our three segments, driving margin expansion and delivering a higher quality of earnings."

For the quarter ended Dec. 31, Becton Dickinson reported a profit of $625.4 million, or $3.13 a share, compared with $263 million, or $1.21 a share, a year earlier. Per-share earnings from continuing operations were $1.35 versus $1.14.

Revenue increased 3.7% to $1.9 billion. Analysts polled by Thomson Reuters most recently forecast earnings of $1.24 a share on revenue of $1.86 billion.

Gross margin widened to 52.9% from 50.8%.

Becton Dickinson's sales grew 3% in the U.S. and 4.3% internationally. The company's medical unit, its largest by revenue, reported sales rose 3.5%. The diagnostics business posted revenue growth 5%, while bioscience revenue was up 1.7%.

Shares closed Monday at $85.16 and were inactive premarket. The stock has risen 11% in the past three months.

Write to Saabira Chaudhuri at saabira.chaudhuri@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Becton, Dickinson and Co., Corning Incorporated
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON DICKINSON AND CO
07/21 BECTON DICKINSON : Trademark Application for "BD VIALON" Filed
07/21 BECTON DICKINSON : "Injection Pen" in Patent Application Approval Process (USPTO..
07/21 BECTON DICKINSON : An Application for the Trademark "BD HYPAK SCF" Has Been File..
07/19 BUSINESS MACHINES : IBM Releases 2015 Corporate Responsibility Report
07/19 BECTON DICKINSON : BD Hits Century Mark With Infusion Pump Interoperability
07/19 BECTON DICKINSON : Combine Solicitation - Becton, Dickinson and Company LSRForte..
07/14 BECTON DICKINSON : Trademark Application for "PRECISIONGLIDE" Filed by Becton Di..
07/14 BECTON DICKINSON : Trademark Application for "BD PRECISIONGLIDE" Filed by Becton..
07/14 BECTON DICKINSON : Special Notice - BD BACTEC Liquid Culture and Mycrobacteria D..
07/14 BECTON DICKINSON : Presolicitation Notice - BD LRS & FACSAria Upgrades
More news
Sector news : Medical Supplies
07/22DJDEXCOM : Shares Rise After FDA Panel Vote
07/21DJSTRYKER : Raises Annual Guidance, but Current Quarter's View Misses Targets
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth -- Update
07/20DJAbbott Labs Profit Tops Views
07/20DJABBOTT LABORATORIES : Labs Profit Tops Views
More sector news : Medical Supplies
News from SeekingAlpha
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/19 RETIREMENT STRATEGY : 5 Dividend Aristocrats To Buy Here
07/19 Dividend Update - June 2016
07/18 MY 80 STOCK PORTFOLIO REVIEW : Revealing All Account Types - Taxable, Roth And O..
07/07 Roche's cobas HPV test for use with cervical cells preserved in SurePath Pres..
Advertisement
Financials ($)
Sales 2016 12 536 M
EBIT 2016 2 604 M
Net income 2016 1 531 M
Debt 2016 10 292 M
Yield 2016 1,50%
P/E ratio 2016 26,36
P/E ratio 2017 21,07
EV / Sales 2016 3,76x
EV / Sales 2017 3,61x
Capitalization 36 853 M
More Financials
Chart BECTON DICKINSON AND CO
Duration : Period :
Becton Dickinson and Co Technical Analysis Chart | BDX | US0758871091 | 4-Traders
Full-screen chart
Technical analysis trends BECTON DICKINSON ...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 182 $
Spread / Average Target 4,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman, President & Chief Executive Officer
Christopher R. Reidy EVP, Chief Financial & Administrative Officer
Ellen R. Strahlman Chief Medical Officer, EVP-Research & Development
Bertram L. Scott Independent Director
Gary A. Mecklenburg Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BECTON DICKINSON AND C..12.71%36 853
TELEFLEX INCORPORATED35.28%7 753
SHANDONG WEIGAO GROUP ..-18.15%2 520
HARTALEGA HOLDINGS BER..--.--%1 758
TOP GLOVE CORPORATION ..--.--%1 354
HOGY MEDICAL CO., LTD.20.56%1 128
More Results